New pacemakers offer 40% more battery life, extend Medtronic legacy of pacing leadership...
Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company...
SIGN discusses medical innovations including Ultrasound Breakthrough in Tumor Treatment, AI and mini robots for brain surgeries...
Most comprehensive and ethnically diverse genomic coverage on a high throughput microarray delivers multi-disease and pharmacogenomic research analysis across global populations...
Agreements Support the Upcoming Launch of VEVYE®...
As a Result of the Agreement, Additional Dental Practices Can Offer This Elevated, Modern Root Canal Treatment That Promotes Pain-free, Fast Healing...
K Health will work with Mayo Clinic to develop and test its bespoke preventative cardiology care technology...
Leading orthopedic provider adopting athenaOne® for its value as a modern and comprehensive suite of EHR, practice management, and patient engagement solutions...
Revolutionizing Dental Care: ICPA Health Products Launches Remin, a Breakthrough Bioactive Glass Toothpaste...
The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside...
